Brevan Howard Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,270
| Closed | -$2.93M | – | 1443 |
|
|
2024
Q4 | $2.93M | Sell |
7,270
-119
| -2% | -$47.9K | 0.02% | 188 |
|
|
2024
Q3 | $3.44M | Buy |
7,389
+2,965
| +67% | +$1.38M | 0.02% | 123 |
|
|
2024
Q2 | $2.07M | Sell |
4,424
-208
| -4% | -$97.5K | 0.02% | 161 |
|
|
2024
Q1 | $1.94M | Sell |
4,632
-198
| -4% | -$82.8K | 0.02% | 114 |
|
|
2023
Q4 | $1.97M | Buy |
4,830
+3,303
| +216% | +$1.34M | 0.02% | 89 |
|
|
2023
Q3 | $531K | Buy |
+1,527
| New | +$531K | 0.01% | 106 |
|